Rapid Evacuation and Access of Cerebral Hemorrhage Registry
ConditionIntracerebral Hemorrhage
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEmory University
About this trial
The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.
Eligibility criteria
Qualifiers
Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage
Hemorrhage volume ≥ 20 mLs
Minimally invasive surgical intervention performed within 7 days of hemorrhage
Disqualifiers
Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (<1 year), as diagnosed with radiographic imaging
Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum
Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms
Last known normal is unknown
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,500 Participants
are grouped into 2 trial groupsSponsors and collaborators
Emory University
Lead sponsor
The Marcus Foundation
Collaborator
Source ClinicalTrials.gov